Skip to main content Back to Top
Advertisement

Hep Hep Hooray! The Evolution of Hepatitis C Therapy

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

IThe speakers will cover a variety of hepatitis C topics, including the current landscape, the evolution of therapies available, the changing role of the pharmacist, and where they see the future of this therapeutic area. 

SPEAKERS

Lindsey Childs-KeanLindsey Childs-Kean, PharmD, MPH, BCPS is a Clinical Assistant Professor in the Department of Pharmacotherapy and Translational Research with the University of Florida College of Pharmacy.  She earned her PharmD degree from University of Florida and completed a PGY1 residency at Tampa General Hospital and a PGY2 Infectious Diseases residency at the South Texas Veterans Healthcare System.  Her teaching, research, and practice interests include infectious disease pharmacotherapy and professional development of students and new practitioners. She is an active member of multiple state and national pharmacy organizations, including a member of the ASHP Section of Clinical Specialists and Scientists Year Round Educational Steering Committee.

Monica MahoneyDr. Monica V. Mahoney is a clinical pharmacy specialist at Beth Israel Deaconess Medical Center in Boston, MA.  She works in the infectious diseases outpatient clinic and in the OPAT clinic.  Dr. Mahoney received her PharmD from MCPHS- Boston and completed PGY1 and PGY2 training in infectious diseases at Tufts Medical Center in Boston, MA.  She is actively involved in a number of pharmacy and infectious diseases society.  Follow her on twitter @mmPharmD



The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.